semaglutide
Semaglutide vs Tirzepatide? Who Protects Liver?
In 2024, a randomized trial found 68% of patients receiving semaglutide achieved sustained abstinence, indicating that both semaglutide and tirzepatide can protect the liver, but semaglutide shows stronger evidence for alcohol-related injury. The finding reshapes how we think about GLP-1 drugs beyond weight loss. Medical Disclaimer: This article is for